90 related articles for article (PubMed ID: 20889349)
1. Polyamide amino acids trimers as TAR RNA ligands and anti-HIV agents.
Bonnard V; Pascale L; Azoulay S; Di Giorgio A; Rogez-Kreuz C; Storck K; Clayette P; Patino N
Bioorg Med Chem; 2010 Nov; 18(21):7432-8. PubMed ID: 20889349
[TBL] [Abstract][Full Text] [Related]
2. Thermodynamic studies of a series of homologous HIV-1 TAR RNA ligands reveal that loose binders are stronger Tat competitors than tight ones.
Pascale L; Azoulay S; Di Giorgio A; Zenacker L; Gaysinski M; Clayette P; Patino N
Nucleic Acids Res; 2013 Jun; 41(11):5851-63. PubMed ID: 23605042
[TBL] [Abstract][Full Text] [Related]
3. Tripeptides from synthetic amino acids block the Tat-TAR association and slow down HIV spread in cell cultures.
Ludwig V; Krebs A; Stoll M; Dietrich U; Ferner J; Schwalbe H; Scheffer U; Dürner G; Göbel MW
Chembiochem; 2007 Oct; 8(15):1850-6. PubMed ID: 17886825
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence correlation spectroscopy at single molecule level on the Tat-TAR complex and its inhibitors.
Nandi CK; Parui PP; Brutschy B; Scheffer U; Göbel M
Biopolymers; 2008 Jan; 89(1):17-25. PubMed ID: 17764074
[TBL] [Abstract][Full Text] [Related]
5. Polyamide amino acids: a new class of RNA ligands.
Bonnard V; Azoulay S; Di Giorgio A; Patino N
Chem Commun (Camb); 2009 May; (17):2302-4. PubMed ID: 19377666
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
Chen S; Chen R; He M; Pang R; Tan Z; Yang M
Bioorg Med Chem; 2009 Mar; 17(5):1948-56. PubMed ID: 19217787
[TBL] [Abstract][Full Text] [Related]
7. Alpha,alpha-trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells.
Wang M; Xu Z; Tu P; Yu X; Xiao S; Yang M
Bioorg Med Chem Lett; 2004 May; 14(10):2585-8. PubMed ID: 15109657
[TBL] [Abstract][Full Text] [Related]
8. 2-Phenylquinolones as inhibitors of the HIV-1 Tat-TAR interaction.
Gatto B; Tabarrini O; Massari S; Giaretta G; Sabatini S; Del Vecchio C; Parolin C; Fravolini A; Palumbo M; Cecchetti V
ChemMedChem; 2009 Jun; 4(6):935-8. PubMed ID: 19283692
[TBL] [Abstract][Full Text] [Related]
9. Deciphering structure-activity relationships in a series of Tat/TAR inhibitors.
Pascale L; González AL; Di Giorgio A; Gaysinski M; Teixido Closa J; Tejedor RE; Azoulay S; Patino N
J Biomol Struct Dyn; 2016 Nov; 34(11):2327-38. PubMed ID: 26524629
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 2-phenylquinolones targeted at Tat/TAR recognition.
Manfroni G; Gatto B; Tabarrini O; Sabatini S; Cecchetti V; Giaretta G; Parolin C; Del Vecchio C; Calistri A; Palumbo M; Fravolini A
Bioorg Med Chem Lett; 2009 Feb; 19(3):714-7. PubMed ID: 19109014
[TBL] [Abstract][Full Text] [Related]
11. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein.
Aboul-ela F; Karn J; Varani G
J Mol Biol; 1995 Oct; 253(2):313-32. PubMed ID: 7563092
[TBL] [Abstract][Full Text] [Related]
12. Scaffold hopping by "fuzzy" pharmacophores and its application to RNA targets.
Tanrikulu Y; Nietert M; Scheffer U; Proschak E; Grabowski K; Schneider P; Weidlich M; Karas M; Göbel M; Schneider G
Chembiochem; 2007 Nov; 8(16):1932-6. PubMed ID: 17896338
[No Abstract] [Full Text] [Related]
13. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
Cao H; Tamilarasu N; Rana TM
Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
[TBL] [Abstract][Full Text] [Related]
14. Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots".
Davis B; Afshar M; Varani G; Murchie AI; Karn J; Lentzen G; Drysdale M; Bower J; Potter AJ; Starkey ID; Swarbrick T; Aboul-ela F
J Mol Biol; 2004 Feb; 336(2):343-56. PubMed ID: 14757049
[TBL] [Abstract][Full Text] [Related]
15. New inhibitors of the Tat-TAR RNA interaction found with a "fuzzy" pharmacophore model.
Renner S; Ludwig V; Boden O; Scheffer U; Göbel M; Schneider G
Chembiochem; 2005 Jun; 6(6):1119-25. PubMed ID: 15883975
[TBL] [Abstract][Full Text] [Related]
16. A Cyclic Mimic of HIV Tat Differentiates Similar TAR RNAs on the Basis of Distinct Dynamic Behaviors.
Lu J; Nguyen L; Zhao L; Xia T; Qi X
Biochemistry; 2015 Jun; 54(23):3687-93. PubMed ID: 26016940
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.
Mei HY; Cui M; Heldsinger A; Lemrow SM; Loo JA; Sannes-Lowery KA; Sharmeen L; Czarnik AW
Biochemistry; 1998 Oct; 37(40):14204-12. PubMed ID: 9760258
[TBL] [Abstract][Full Text] [Related]
18. Amino disaccharides having an alpha-(1-->4) or a beta-(1-->4) linkage, their synthesis and evaluation as a potential inhibitor for HIV-1 TAR-Tat.
Iguchi T; Ishikawa H; Matumoto H; Mizuno M; Goto K; Hamasaki K
Nucleic Acids Symp Ser (Oxf); 2005; (49):169-70. PubMed ID: 17150687
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and bioactivities of TAR RNA targeting beta-carboline derivatives based on Tat-TAR interaction.
Yu X; Lin W; Pang R; Yang M
Eur J Med Chem; 2005 Sep; 40(9):831-9. PubMed ID: 15925430
[TBL] [Abstract][Full Text] [Related]
20. Structural mimicry of retroviral tat proteins by constrained beta-hairpin peptidomimetics: ligands with high affinity and selectivity for viral TAR RNA regulatory elements.
Athanassiou Z; Dias RL; Moehle K; Dobson N; Varani G; Robinson JA
J Am Chem Soc; 2004 Jun; 126(22):6906-13. PubMed ID: 15174860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
